Bionano Genomics (NASDAQ:BNGO) Trading Up 5.5% - Still a Buy?

Bionano Genomics, Inc. (NASDAQ:BNGO - Get Free Report)'s stock price traded up 5.5% on Wednesday . The stock traded as high as $5.36 and last traded at $5.35. 165,486 shares changed hands during trading, a decline of 52% from the average session volume of 341,812 shares. The stock had previously closed at $5.07.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH cut Bionano Genomics from a "buy" rating to a "neutral" rating in a research report on Friday, November 15th.

Bionano Genomics Trading Up 1.3 %

The stock has a market cap of $600.38 million, a P/E ratio of -2.21 and a beta of 2.22. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.99. The business's 50 day simple moving average is $13.26 and its 200 day simple moving average is $21.55.

Institutional Trading of Bionano Genomics

Several hedge funds have recently modified their holdings of the stock. Carret Asset Management LLC boosted its position in Bionano Genomics by 89.0% in the 3rd quarter. Carret Asset Management LLC now owns 85,055 shares of the company's stock valued at $39,000 after buying an additional 40,055 shares during the last quarter. GSA Capital Partners LLP bought a new position in Bionano Genomics in the third quarter valued at about $46,000. Finally, Geode Capital Management LLC increased its position in Bionano Genomics by 47.3% in the third quarter. Geode Capital Management LLC now owns 882,854 shares of the company's stock worth $401,000 after purchasing an additional 283,639 shares during the period. 11.35% of the stock is owned by institutional investors.

Bionano Genomics Company Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.